ResearcherMemorial Sloan Kettering Cancer CenterNo recent work listed
Murray F. Brennan
Matched on ORCID iD 0000-0003-2358-4371; OpenAlex author ID A5075518419. Sources: OpenAlex.
Their work
- Papers
- 9 (first author 1, last author 1)
- Trials
- 0
- Grants
- 0
- Labs led
- 0
- Collaborators
- 23
2011: 3 papers · 2012: 5 papers · 2013: none · 2014: none · 2015: none · 2016: 1 paper
Papers 9
- Human Trial of a Genetically Modified Herpes Simplex Virus for Rapid Detection of Positive Peritoneal Cytology in the Staging of Pancreatic Cancer. Co-author DOI 10.1016/j.ebiom.2016.03.043↗
- Operative procedures for unresectable pancreatic cancer: does operative bypass decrease requirements for postoperative procedures and in-hospital days? Co-author DOI 10.1111/j.1477-2574.2012.00477.x↗
- Survival after resection of pancreatic adenocarcinoma: results from a single institution over three decades. First author DOI 10.1245/s10434-011-1900-3↗
- Downstaging in pancreatic cancer: a matched analysis of patients resected following systemic treatment of initially locally unresectable disease. Co-author DOI 10.1245/s10434-011-2156-7↗
- Impact of obesity and body fat distribution on survival after pancreaticoduodenectomy for pancreatic adenocarcinoma. Co-author DOI 10.1245/s10434-012-2301-y↗
- A novel survival-based tissue microarray of pancreatic cancer validates MUC1 and mesothelin as biomarkers. Co-author DOI 10.1371/journal.pone.0040157↗
- Targeting mutated K-ras in pancreatic adenocarcinoma using an adjuvant vaccine. Co-author DOI 10.1097/coc.0b013e3181e84b1f↗
- Invasive carcinoma arising in intraductal papillary mucinous neoplasms of the pancreas: a matched control study with conventional pancreatic ductal adenocarcin… Co-author DOI 10.1097/sla.0b013e318214bcb4↗
- Prospective evaluation of laparoscopic celiac plexus block in patients with unresectable pancreatic adenocarcinoma. Last author DOI 10.1245/s10434-010-1372-x↗
Closest collaborators
The 23 strongest of 23 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Peter J. Allen · 8 shared papers, 2011–2016 · strength 0.26
- Paper Human Trial of a Genetically Modified Herpes Simplex Virus for Rapid Detection of Positive Peritoneal Cytology in the S… DOI 10.1016/j.ebiom.2016.03.043↗
- Paper Prospective evaluation of laparoscopic celiac plexus block in patients with unresectable pancreatic adenocarcinoma. DOI 10.1245/s10434-010-1372-x↗
- Paper Survival after resection of pancreatic adenocarcinoma: results from a single institution over three decades. DOI 10.1245/s10434-011-1900-3↗
- Yuman Fong MD · 7 shared papers, 2011–2016 · strength 0.23
- Paper Human Trial of a Genetically Modified Herpes Simplex Virus for Rapid Detection of Positive Peritoneal Cytology in the S… DOI 10.1016/j.ebiom.2016.03.043↗
- Paper Survival after resection of pancreatic adenocarcinoma: results from a single institution over three decades. DOI 10.1245/s10434-011-1900-3↗
- Paper Operative procedures for unresectable pancreatic cancer: does operative bypass decrease requirements for postoperative … DOI 10.1111/j.1477-2574.2012.00477.x↗
- Michael Ian D'Angelica · 6 shared papers, 2011–2012 · strength 0.17
- Paper Survival after resection of pancreatic adenocarcinoma: results from a single institution over three decades. DOI 10.1245/s10434-011-1900-3↗
- Paper Operative procedures for unresectable pancreatic cancer: does operative bypass decrease requirements for postoperative … DOI 10.1111/j.1477-2574.2012.00477.x↗
- Paper Downstaging in pancreatic cancer: a matched analysis of patients resected following systemic treatment of initially loc… DOI 10.1245/s10434-011-2156-7↗
- William R. Jarnagin · 6 shared papers, 2011–2012 · strength 0.17
- Paper Survival after resection of pancreatic adenocarcinoma: results from a single institution over three decades. DOI 10.1245/s10434-011-1900-3↗
- Paper Operative procedures for unresectable pancreatic cancer: does operative bypass decrease requirements for postoperative … DOI 10.1111/j.1477-2574.2012.00477.x↗
- Paper Downstaging in pancreatic cancer: a matched analysis of patients resected following systemic treatment of initially loc… DOI 10.1245/s10434-011-2156-7↗
- Daniel G. Coit · 2 shared papers, 2011–2016 · strength 0.10
- Paper Human Trial of a Genetically Modified Herpes Simplex Virus for Rapid Detection of Positive Peritoneal Cytology in the S… DOI 10.1016/j.ebiom.2016.03.043↗
- Paper Prospective evaluation of laparoscopic celiac plexus block in patients with unresectable pancreatic adenocarcinoma. DOI 10.1245/s10434-010-1372-x↗
- Eileen Mary O'Reilly · 3 shared papers, 2011–2012 · strength 0.08
- Paper Downstaging in pancreatic cancer: a matched analysis of patients resected following systemic treatment of initially loc… DOI 10.1245/s10434-011-2156-7↗
- Paper A novel survival-based tissue microarray of pancreatic cancer validates MUC1 and mesothelin as biomarkers. DOI 10.1371/journal.pone.0040157↗
- Paper Targeting mutated K-ras in pancreatic adenocarcinoma using an adjuvant vaccine. DOI 10.1097/coc.0b013e3181e84b1f↗
- Kaitlyn Jane Kelly · 1 shared paper, 2016 · strength 0.07
- Jordan Michael Winter · 2 shared papers, 2012 · strength 0.06
- T. Peter Kingham · 1 shared paper, 2012 · strength 0.03
- Camilo Correa‐Gallego · 1 shared paper, 2012 · strength 0.03
- John Lyons · 1 shared paper, 2012 · strength 0.03
- Kai A. Bickenbach · 1 shared paper, 2012 · strength 0.03
- Karyn A. Goodman · 1 shared paper, 2012 · strength 0.03
- Sara H. Olson · 1 shared paper, 2012 · strength 0.03
- Sébastien Gaujoux · 1 shared paper, 2012 · strength 0.03
- Michael Garrett House · 1 shared paper, 2012 · strength 0.03
- Flavio G. Rocha · 1 shared paper, 2012 · strength 0.03
- Robert C. Kurtz · 1 shared paper, 2012 · strength 0.03
- Jonathan Robert Brody · 1 shared paper, 2012 · strength 0.03
- Adam Charles Yopp · 1 shared paper, 2011 · strength 0.03
- Marinela Capanu · 1 shared paper, 2011 · strength 0.02
- Ghassan K. Abou‐Alfa · 1 shared paper, 2011 · strength 0.02
- David Paul Kelsen · 1 shared paper, 2011 · strength 0.02
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.